ESR1 and hepatocellular carcinoma: Our findings complement prior work that has demonstrated a role for CKB in promoting cell survival, migration, chemotaxis, and metastasis in hepatocellular carcinoma, pancreatic ductal adenocarcinoma, prostate cancer, osteosarcoma, and estrogen receptor–negative breast cancer (6, 11, 50, 51, 52).